| Product Code: ETC8535749 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Continuous Subcutaneous Insulin Infusion Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Continuous Subcutaneous Insulin Infusion Market - Industry Life Cycle |
3.4 Netherlands Continuous Subcutaneous Insulin Infusion Market - Porter's Five Forces |
3.5 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.7 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Netherlands Continuous Subcutaneous Insulin Infusion Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the Netherlands |
4.2.2 Growing awareness about the benefits of continuous subcutaneous insulin infusion therapy |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 High cost associated with continuous subcutaneous insulin infusion therapy |
4.3.2 Limited reimbursement policies for insulin infusion devices |
4.3.3 Regulatory challenges and approvals for new devices |
5 Netherlands Continuous Subcutaneous Insulin Infusion Market Trends |
6 Netherlands Continuous Subcutaneous Insulin Infusion Market, By Types |
6.1 Netherlands Continuous Subcutaneous Insulin Infusion Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Tethered, 2021- 2031F |
6.1.4 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Patch, 2021- 2031F |
6.2 Netherlands Continuous Subcutaneous Insulin Infusion Market, By End Use |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3 Netherlands Continuous Subcutaneous Insulin Infusion Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 1 diabetes, 2021- 2031F |
6.3.3 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 2 diabetes, 2021- 2031F |
7 Netherlands Continuous Subcutaneous Insulin Infusion Market Import-Export Trade Statistics |
7.1 Netherlands Continuous Subcutaneous Insulin Infusion Market Export to Major Countries |
7.2 Netherlands Continuous Subcutaneous Insulin Infusion Market Imports from Major Countries |
8 Netherlands Continuous Subcutaneous Insulin Infusion Market Key Performance Indicators |
8.1 Patient adherence rate to continuous subcutaneous insulin infusion therapy |
8.2 Rate of adoption of new insulin infusion technologies in the Netherlands |
8.3 Number of healthcare providers offering continuous subcutaneous insulin infusion therapy services |
9 Netherlands Continuous Subcutaneous Insulin Infusion Market - Opportunity Assessment |
9.1 Netherlands Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Netherlands Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.3 Netherlands Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 Netherlands Continuous Subcutaneous Insulin Infusion Market - Competitive Landscape |
10.1 Netherlands Continuous Subcutaneous Insulin Infusion Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Continuous Subcutaneous Insulin Infusion Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here